2741952-35-0
Chemical Structure
Cap-dependent endonuclease-IN-21
- CAS No.: 2741952-35-0
- Formula:C26H23F2N3O7
- Molecular Weight:527.47
IUPAC Name: (((7aS,16R)-2,3-difluoro-8-methyl-9,11-dioxo-16-phenyl-6,7,7a,8,9,11-hexahydro-16H-benzo[b]pyrido[1',2':1,6][1,2,4]triazino[2,3-e][1,5]oxazocin-10-yl)oxy)methyl methyl carbonate
InChIKey: NKFNQBUTOXCBGL-FCHUYYIVSA-N
SMILES: CN1[C@@]2([H])N(N3C(C1=O)=C(C(C=C3)=O)OCOC(OC)=O)[C@@](C4=CC=CC=C4)([H])C5=CC(F)=C(F)C=C5OCC2
Biological Activity: Cap-dependent endonuclease-IN-21 is a potent inhibitor of cap-dependent endonuclease (CEN). Cap-dependent endonuclease-IN-21 inhibits the replication of influenza virus. ap-dependent endonuclease-IN-21 has the potential for the research of influenza virus infection (influenza A) (extracted from patent WO2021233302A1, compound 8B or 8A)[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Cap-dependent endonuclease-IN-21 | Cap-dependent endonuclease-IN-21 is a potent inhibitor of cap-dependent endonuclease (CEN). Cap-dependent endonuclease-IN-21 inhibits the replication of influenza virus. ap-dependent endonuclease-IN-21 has the potential for the research of influenza virus infection (influenza A) (extracted from patent WO2021233302A1, compound 8B or 8A). | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
Keywords
